CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
Price to Sales HistoryNormalizing
Percentile Rank50
3Y CAGR+57.4%
5Y CAGR+11.8%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+57.4%/yr
vs -34.2%/yr prior
5Y CAGR
+11.8%/yr
Recent acceleration
Acceleration
+91.6pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 7.71 | +1124.5% |
| 2024 | 0.63 | -44.3% |
| 2023 | 1.13 | -42.9% |
| 2022 | 1.98 | -73.4% |
| 2021 | 7.44 | +68.5% |
| 2020 | 4.42 | -32.6% |
| 2019 | 6.55 | -38.0% |
| 2018 | 10.57 | -3.5% |
| 2017 | 10.95 | -58.6% |
| 2016 | 26.47 | - |